Smith Kevin Raymond Merrill bought INGN
March 1, 2026 · Form 4 insider transaction
Smith Kevin Raymond Merrill bought 32,725 shares of Inogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,725
Price
$0.00
Total value
N/A
InsiderSmith Kevin Raymond Merrill
RoleOfficer, Director
CompanyInogen, Inc. (INGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after119,701
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023.